Amanote Research

Amanote Research

    RegisterSign In

(Not Giving Up) the Marathon Race of MET Targeting Therapy: Are We There Yet?

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3739
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

February 15, 2019

Authors
Patrick C. Ma
Publisher

American Association for Cancer Research (AACR)


Related search

Predicting Delirium: Are We There Yet?

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2017English

Cancer Immunotherapy: Are We There Yet?

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2013English

Clinical Proteomics: Are We There Yet?

Analytical Chemistry
Analytical Chemistry
2003English

Personalized Medicine: Are We There Yet?

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2008English

Are We Half-Way There Yet?

Journal of Education for Sustainable Development
2009English

Vascular Endothelial Growth Factor Therapy for the Kidney: Are We There Yet?

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Personalized Cancer Medicine: Are We There Yet?

Oncologist
Cancer ResearchMedicineOncology
2013English

Corticosteroids for Pneumonia: Are We There Yet?

Respirology
PulmonaryRespiratory Medicine
2013English

RNA-Seq Assembly – Are We There Yet?

Frontiers in Plant Science
Plant Science
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy